Cureus

Long-Term Clinical Outcomes and Real-World Effectiveness of Tirzepatide in Adults With Overweight or Obesity: A Systematic Review

By Aliyu Olanrewaju Olaniyi, Khyathi Krishna Gogineni, Happiness Olaniyi, Nazeem Gabriels

Figure 1. PRISMA 2020 Flow Diagram for the Study Selection Process. — Figure 1. PRISMA 2020 Flow Diagram for the Study Selection Process.PRISMA 2020 Flow Diagram for the Study Selection Process.Olaniyi et al.

Systematic review of studies in peopleInterventions

Dose-response, declared no competing interests

The paper

Aliyu Olanrewaju Olaniyi, Khyathi Krishna Gogineni, Happiness Olaniyi, Nazeem Gabriels

Stepping Hill Hospital; Stockport NHS Foundation Trust

Cureus, 22 Aug 2026

doi.org/10.7759/cureus.114962 PubMed 42769739

The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity